Global Intracranial Stents Market - Snapshot
The global intracranial stents market has expanded significantly over the last two decades, and the market has been characterized by technological innovation and increase in preference for intracranial stents for the treatment of intracranial stenosis and management of stroke. Rapid rise in the geriatric population, increase in incidence of chronic neurological diseases, and high research and development activities in the field of stroke management and chronic neurological diseases are major environmental factors that drive the intracranial stents market. However, tight budgetary constraints faced by intracranial stents manufacturers and healthcare service providers are key factors that, currently, restrain the market.
High demand for minimally-invasive procedures, availability of embolic devices, and rising prevalence of intracranial atherosclerosis disease across the world, due to increase in risk factors such as hypertension, diabetes, and obesity, are likely to drive the market during the forecast period. Technical advances, such as rapid innovation in the field of self-expanding stents and improvement in flexibility of the stents, are primary influences of the intracranial stents market. Increase in health care expenditure and expansion of the medical devices industry propel the intracranial stents market globally. Changing health care reforms, increase in government initiatives, and rise in the number of product manufacturers targeting the emerging regions are expected to drive the intracranial stents market in various regions during the forecast period.
The global intracranial stents market was valued at US$ 298.7 Mn in 2017 and is anticipated to reach US$ 705.5 Mn by 2026, expanding at a CAGR of 10.4% from 2018 to 2026. Increasing prevalence of chronic diseases in the geriatric population, favorable reimbursement scenario, and increasing government initiatives toward geriatrics are expected to boost the intracranial stents market during the forecast period.
The global intracranial stents market has been segmented based on product type, disease indication, end-user, and region. In terms of product type, the intracranial stents market has been divided into self-expanding stents, balloon expanding stents, and stent-assisted coil embolization. In terms of disease indication, the market has been segregated into intracranial stenosis and brain aneurysm. The self-expanding stents segment accounted for a prominent share of the market, in terms of revenue, in 2017. The segment is also expected to expand at a CAGR of 11.7% during the forecast period.
In terms of region, North America accounted for a leading share of the global intracranial stents market, in terms of revenue, followed by Europe. High prevalence of neurological diseases coupled with the presence of sophisticated healthcare infrastructure and rising per capita healthcare expenditure are boosting the market in the region. Moreover, strong research and development activities in the region promoting the development of new neurology devices have contributed to the significant market share held by the region in the global intracranial stents market. Contribution of revenue from the developed countries in Western Europe, such as the U.K., Germany, France, and Italy, is responsible for the prominent share held by Europe in the global market. The amplifying base of the target patient population, i.e., geriatric people (over the age of 65 years), is anticipated to drive the intracranial stents market in Europe during the forecast period.
The intracranial stents market in Asia Pacific is expected to expand at a significant pace due to developing healthcare infrastructure and increasing government support for people. Other regions, such as Middle East & Africa and Latin America, are expected to be lucrative markets for intracranial stents in the near future, due to the high rate of adoption of advanced medical devices coupled with the rapid expansion of the health care industry in these regions.
Prominent players operating in the global intracranial stents market include Penumbra, Inc., Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Johnson & Johnson Services, Inc., Terumo Corporation, and Cook Medical.
Global Intracranial Stents Market: Overview
This report on the global intracranial stents market analyzes the current and future prospects of the market. The report comprises a comprehensive executive summary, including a market snapshot that provides overall information of various segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market value in terms of US$ Mn for each segment for the period from 2016 to 2026, considering the macro and micro environmental factors. Growth rates for each segment within the global intracranial stents market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
A detailed qualitative analysis of factors responsible for driving and restraining the market and future opportunities has been provided in the market overview section. The report also provides insights into the key trends of the intracranial stents market. Market value in terms of US$ Mn for the period between 2016 and 2026 along with the compound annual growth rate (CAGR %) from 2018 to 2026 are provided for all the segments, considering 2017 as the base year. The year-on-year growth of the global intracranial stents market for each segment is also reflected. Additionally, market-related factors such as increasing prevalence of chronic disease, rising geriatric population, favorable government policies, developing healthcare infrastructure in emerging countries, and historical year-on-year growth have been taken into consideration while estimating the market size.
Global Intracranial Stents Market: Key Segments
The global intracranial stents market has been segmented based on product type, disease indication, end-user, and region. In terms of product type, the intracranial stents market has been divided into self-expanding stents, balloon expanding stents and stent-assisted coil embolization. In terms of disease indication, the market has been segregated into intracranial stenosis and brain aneurysm. In terms of end-user, the market has been classified into, hospitals, ambulatory surgical centers, and others
Global Intracranial Stents Market: Regional Outlook
In terms of region, the global intracranial stents market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Additionally, the regions have been further segmented into major countries in each of the regions. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Australia & New Zealand, Japan, India, Brazil, GCC, South Africa, and Mexico.
Companies Mentioned in Report
The report also profiles major players in the intracranial stents market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Penumbra, Inc., Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Johnson & Johnson Services, Inc., Terumo Corporation, and Cook Medical.
The global intracranial stents market has been segmented as follows:
Global Intracranial Stents Market, by Product Type
- Self-expanding Stents
- Balloon Expanding Stents
- Stent-assisted Coil Embolization
Global Intracranial Stents Market, by Disease Indication
- Intracranial Stenosis
- Brain Aneurysm
Global Intracranial Stents Market, by End-user
- Ambulatory Surgical Centers
Global Intracranial Stents Market, by Region
- North America
- Rest of Europe
- Asia Pacific
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America (LATAM)
- Rest of Latin America
- Middle East & Africa (MEA)
- South Africa
- Rest of Middle East & Africa